Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

× No keyword cloud information.

62 in total

1. Scaffold hopping for identification of novel D(2) antagonist based on 3D pharmacophore modelling of illoperidone analogs.

Authors: Radha Charan Dash; Sharad H Bhosale; Suhas M Shelke; Mugdha R Suryawanshi; Ashish M Kanhed; Kakasaheb R Mahadik
Journal: Mol Divers Date: 2011-12-08 Impact factor: 2.943

2. Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors: Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal: Synapse Date: 2011-03-21 Impact factor: 2.562

3. A new approach for structure analysis of two-dimensional membrane protein crystals using X-ray powder diffraction data.

Authors: R A Dilanian; C Darmanin; J N Varghese; S W Wilkins; T Oka; N Yagi; H M Quiney; K A Nugent
Journal: Protein Sci Date: 2011-01-18 Impact factor: 6.725

Review 4. Dopamine Receptors and Neurodegeneration.

Authors: Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal: Aging Dis Date: 2015-10-01 Impact factor: 6.745

5. Characterization of the 5' flanking region of the human D1A dopamine receptor gene.

Authors: M T Minowa; T Minowa; F J Monsma; D R Sibley; M M Mouradian
Journal: Proc Natl Acad Sci U S A Date: 1992-04-01 Impact factor: 11.205

6. Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease.

Authors: Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal: J Pharmacokinet Pharmacodyn Date: 2005-08 Impact factor: 2.745

7. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.

Authors: Jo Ann V Antenor-Dorsey; Joanne Markham; Stephen M Moerlein; Tom O Videen; Joel S Perlmutter
Journal: Nucl Med Biol Date: 2008-04 Impact factor: 2.408

8. Dopamine receptors in the Parkinsonian brain.

Authors: U K Rinne; P Lönnberg; V Koskinen
Journal: J Neural Transm Date: 1981 Impact factor: 3.575

Review 9. Anti-parkinsonian drugs today.

Authors: N P Quinn
Journal: Drugs Date: 1984-09 Impact factor: 9.546

10. Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

Authors: Jean-Christophe Corvol; Marie-Paule Muriel; Emmanuel Valjent; Jean Féger; Naïma Hanoun; Jean-Antoine Girault; Etienne C Hirsch; Denis Hervé
Journal: J Neurosci Date: 2004-08-04 Impact factor: 6.167